The global Flow Cytometry Market size is expected to reach USD 8.92 billion by 2026 registering a CAGR of 10.6%, according to a new report by Grand View Research, Inc. Increasing incidence of infectious diseases and cancer is expected to upsurge the demand for flow cytometers for disease diagnosis. In addition, rising usage of autologous and allogenic stem cell therapy by physicians, due to adverse effects of radiation and chemotherapy in the treatment of cancer, will also drive the market.
High demand for Point-of-Care (PoC) testing in chronic
disease management is also expected to fuel the demand for cytometry
techniques. Increasing R&D initiatives by key companies for the development
of multicolor assays and advanced reagents for analysis are anticipated to
boost the demand further. Furthermore, technological advancements, in terms of
enhanced accuracy, portability, and cost-effectiveness, are expected to offer
lucrative growth opportunities for the market.
Small-size high-throughput cytometers are expected to
gain popularity over the coming years as they are cost-effective and easy to
use. Furthermore, improvement in fluorescent dyes and introduction of bench top
cytometers are the other growth propellers. For instance, multicolor flow
cytometry coupled with multiple lasers is the fastest-growing application
segment, which finds extensive applications in the field of R&D innovations
in new drug development and is adopted by many Contract Research Organizations
(CRO).
Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/flow-cytometry-market
Further key findings from the study
suggest:
- Bead-based flow cytometry is anticipated to witness the highest CAGR
over the forecast period owing to increasing advancements in molecular
engineering and monoclonal antibody production
- Reagent & consumable is anticipated to be the fastest-growing
product & services segment from 2019 to 2026 due to extensive
utilization in molecular diagnostics
- Commercial organizations segment held the largest revenue share due
to large-scale production of proteins, cell line development, and other
biologicals coupled with high demand for cell sorting and analysis
techniques
- Asia Pacific regional is presumed to witness the fastest CAGR from
2019 to 2025 owing to supportive government initiatives for the
development of biotech industry and growing awareness about the
applications of flow cytometers
- Multinational companies are collaborating with local diagnostic
companies and healthcare institutions in developing countries to
strengthen their position in the global flow cytometry market
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment